Results 221 to 230 of about 1,541,253 (387)
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
R. Schrier +6 more
semanticscholar +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Thrombin induces degradation of murine intervertebral discs via angiogenesis and M1-like polarization of macrophages. [PDF]
Tatsuno R +5 more
europepmc +1 more source
Studies on Nucleic Acid Antagonists. I. Syntheses of 5-Phenylazopyrimidines.
Kuniyoshi Tanaka +6 more
openalex +2 more sources
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha +10 more
wiley +1 more source
Evaluation of the effects of the Stop GnRH agonist with the letrozole protocol in poor ovarian responders: ABOTH randomized controlled trial. [PDF]
Saharkhiz N +7 more
europepmc +1 more source
Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Ho Min Kim +10 more
semanticscholar +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Utility of GnRH Agonists before embryo transfer in women with adenomyosis: Systematic review and meta-analysis. [PDF]
González-Comadran M +3 more
europepmc +1 more source

